FFOII :COI1I']ER:]A* !FF]'E JAI(ARTII FA,{ lt!, ,!: t1l;81i7 DE.. E1 !01@ E.1l lEPll F3
The 3rd
IntrI
EharrMceuticals ' Chentcals, Cosmetics e Medica] Equipn.rltExhlbltion 6nd confe!ence
.h€mtech- E';YET LOCC
chonrech tgyp! & Fhalma Biotcch Exhibition 3nd cdnfelence
tbe:rrd eclrjd'
and6iI1
beheld
ln CICC
llas!City
_ Cailo- Egy?t
During ? 9 r,av, 2011.Chenre.h
will
cover Equj.pnentfor
Chemrc.Is, Pharnaceuticals,fertj.l:zei5
and 'ithe!P.ocess lndustr:€s, Proces6 Engtnee!ing, Procu!€nent
/
cansutanit
servl.es/ lnstrumentarion, Con!rol!
Autoilstion EquiPfi€it/ Soft{3re, I'laterial
NanSlingEquiFnort, Packagilg systehs/ Hachinerv &
Materrals,
eld:ng ./Pla.t
lrarntenanceServices,
rniusrrial
coDsunables,Aiafy:ical t
iaboratory aquiprert/
Conslrab].sQu;Ii!y, realth,
Safety & Environnent. Dh6ira-b:o- tecb EGYPTiha:rarecr !il:
!ove- equipn.Etf6!
pliarn,4c€utictl prDpa!arionvedic.I
Devrces, rnd1!pplicatlonsi Fharftaceuiicals/Med!arne, Envl!onnen:, cosreEics. !a.c:atory,
AralytI.aI,
!la])1ostic EquiprenE and Methods, Cheri\ic6l.Systers,
PhaYnacelt:celtlaterials
d 5!pp1res, PhajilracculiEal paeklng equiPn€n!, Vedicel €qujpFent arechncLoqy, Pehebilitation equifl!€nt, He:lth cdnsultancy,
ie:ith
aare se:.!ces &plbli.atrrn,
Bic Chenicals. MEdica-l ResearchCent.ls,
PDb:icati^ns & serlice praeide!E, FR agenciest corsuliation
Pharftaceullcals, Tec:lnoloqres. Flr.ess plantMachinelly, Aliernative Medicines, Phahaceuticals & Druqs and tetelj.nary
phahaceutj cais.
T5e corieren.e p!ovides sDprefte netsor\i:rq €PFortunrtres
fo!:,-iesrtes:c
mEet$iih
high leveL repleientativestlon
govelnrnentsr.d FeIl
estaLrllEhed cnamjcEl 6,pila:ri€ceuticalt cohpanres.
FREII : CI]TI'1EFC ] A OFFI'E JAI'ffRTF
si9atuf,e
Mobamed Hannad yr!ke!ing blanager
Mobile: +2012 r564 203
FA:r ftd, :a:1319261?? IJE|. EL :E1O 6a::LlPI1 F5
t/5
Mob:I€r +2
al|
15642O3
_c1I
64i5842
'
Ol0 1214 969San6 Narlcrinq Blsinee6 st4B Co
loio s$b coLor
167.1 +2A2 338 79 ?68
-
02 13s39{55 -
3385r
913Fax: +202 :3r39 456
glebsit€: wwl!. straegyP:.
c.n {http!,//!!w
smbegyPt com>Erail:
inf.l!snb:qyi_t.cor.na1lto:irrfoGs D*gvPtcoh!
-
3t'lrenh'ogniil cbn 4nailto:
snbexh0qna!:. cotr>7ie are pL.ased
ro invite all
thoseirterested in
lhe €bcvetlehe to subrir
abstract!cn
plefeiiLry
r€search based papers focusihg on on€of
the con:erence oblE.trvesInsr:ucr'c\s f_r
aak:nJAb€t'.ci
].
Theoffic-dI l,ngl"le rs
Englj:h.2.
0se tlicrosoJt l,lord fo!nat.l.
Abstaac-- Jorrat I1)
Titl€ cf
theabs:ract. {rn ]o{er
case and shodld be ce!]tered. )3) Marling aiciress
for
p:crenting author. 4) Abstract body, iAbout 60c aofdsor
lPaqe)5)
TiFe3 (tieel soianion! in
12pt
size and sing]€Iine
3pacinq.6) 2.:lch 6ach.'lFIr
.r,d ,rqhL pale ad!9:ns.Selected
fulL
pape!s sh.ul4 be subnit[edconferencc top:cs
Autocont!o1 Tecllno-togy
tn
PbarftaceuticalChemical ProcesseB
in
AlrnosFhele+2010
t2t4
969I
Deacline abstract subnit
FF0t1 : CLr|"flERC I F- OFFICE JFrl.FrRTFl FFr! fro. r421319?61?? De.. aL 2E1E 6:l: LEPI1 P.l
EG
5
chefric.l Risk Mitigatidn and Analysts5
chenicals plocess control aDds,tmurdrion
S
Elecrrochenicat and Flochehtc.r propelriesand AF,pt'icafiEns
S
E.iectronlc p.operri€s and Device AppricationsS
Erergy and enviroDnent5
Impactof A:!
&iiesiods cn Husan Healrhs
Industrla_l chen!.al Pol t utrof,5
M6tchirg the pharnaceutical propelrresto
l,reolcine Ef:ecr.S
Ned te.hnotog:es and sol.urionsof
ch€nicals &pharFa:eut:.eLs-I
?.talmaceuticals process ,noceting snd optjntzct:ont soll
Contrrlnation andpotlution
plevenrion